Reliable quantification of 18F-GE-180 PET neuroinflammation studies using an individually scaled population-based input function or late tissue-to-blood ratio

Standard

Reliable quantification of 18F-GE-180 PET neuroinflammation studies using an individually scaled population-based input function or late tissue-to-blood ratio. / Buchert, Ralph; Dirks, Meike; Schütze, Christian; Wilke, Florian; Mamach, Martin; Wirries, Ann-Katrin; Pflugrad, Henning; Hamann, Linda; Langer, Laura B N; Wetzel, Christian; Lukacevic, Mario; Polyak, Andras; Kessler, Mariella; Petrusch, Carlotta; Bengel, Frank M; Geworski, Lilli; Rupprecht, Rainer; Weissenborn, Karin; Ross, Tobias L; Berding, Georg.

In: EUR J NUCL MED MOL I, Vol. 47, No. 12, 11.2020, p. 2887-2900.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Buchert, R, Dirks, M, Schütze, C, Wilke, F, Mamach, M, Wirries, A-K, Pflugrad, H, Hamann, L, Langer, LBN, Wetzel, C, Lukacevic, M, Polyak, A, Kessler, M, Petrusch, C, Bengel, FM, Geworski, L, Rupprecht, R, Weissenborn, K, Ross, TL & Berding, G 2020, 'Reliable quantification of 18F-GE-180 PET neuroinflammation studies using an individually scaled population-based input function or late tissue-to-blood ratio', EUR J NUCL MED MOL I, vol. 47, no. 12, pp. 2887-2900. https://doi.org/10.1007/s00259-020-04810-1

APA

Buchert, R., Dirks, M., Schütze, C., Wilke, F., Mamach, M., Wirries, A-K., Pflugrad, H., Hamann, L., Langer, L. B. N., Wetzel, C., Lukacevic, M., Polyak, A., Kessler, M., Petrusch, C., Bengel, F. M., Geworski, L., Rupprecht, R., Weissenborn, K., Ross, T. L., & Berding, G. (2020). Reliable quantification of 18F-GE-180 PET neuroinflammation studies using an individually scaled population-based input function or late tissue-to-blood ratio. EUR J NUCL MED MOL I, 47(12), 2887-2900. https://doi.org/10.1007/s00259-020-04810-1

Vancouver

Bibtex

@article{30065ccf0503434f8c98eeeac43df5bd,
title = "Reliable quantification of 18F-GE-180 PET neuroinflammation studies using an individually scaled population-based input function or late tissue-to-blood ratio",
abstract = "PURPOSE: Tracer kinetic modeling of tissue time activity curves and the individual input function based on arterial blood sampling and metabolite correction is the gold standard for quantitative characterization of microglia activation by PET with the translocator protein (TSPO) ligand 18F-GE-180. This study tested simplified methods for quantification of 18F-GE-180 PET.METHODS: Dynamic 18F-GE-180 PET with arterial blood sampling and metabolite correction was performed in five healthy volunteers and 20 liver-transplanted patients. Population-based input function templates were generated by averaging individual input functions normalized to the total area under the input function using a leave-one-out approach. Individual population-based input functions were obtained by scaling the input function template with the individual parent activity concentration of 18F-GE-180 in arterial plasma in a blood sample drawn at 27.5 min or by the individual administered tracer activity, respectively. The total 18F-GE-180 distribution volume (VT) was estimated in 12 regions-of-interest (ROIs) by the invasive Logan plot using the measured or the population-based input functions. Late ROI-to-whole-blood and ROI-to-cerebellum ratio were also computed.RESULTS: Correlation with the reference VT (with individually measured input function) was very high for VT with the population-based input function scaled with the blood sample and for the ROI-to-whole-blood ratio (Pearson correlation coefficient = 0.989 ± 0.006 and 0.970 ± 0.005). The correlation was only moderate for VT with the population-based input function scaled with tracer activity dose and for the ROI-to-cerebellum ratio (0.653 ± 0.074 and 0.384 ± 0.177). Reference VT, population-based VT with scaling by the blood sample, and ROI-to-whole-blood ratio were sensitive to the TSPO gene polymorphism. Population-based VT with scaling to the administered tracer activity and the ROI-to-cerebellum ratio failed to detect a polymorphism effect.CONCLUSION: These results support the use of a population-based input function scaled with a single blood sample or the ROI-to-whole-blood ratio at a late time point for simplified quantitative analysis of 18F-GE-180 PET.",
author = "Ralph Buchert and Meike Dirks and Christian Sch{\"u}tze and Florian Wilke and Martin Mamach and Ann-Katrin Wirries and Henning Pflugrad and Linda Hamann and Langer, {Laura B N} and Christian Wetzel and Mario Lukacevic and Andras Polyak and Mariella Kessler and Carlotta Petrusch and Bengel, {Frank M} and Lilli Geworski and Rainer Rupprecht and Karin Weissenborn and Ross, {Tobias L} and Georg Berding",
year = "2020",
month = nov,
doi = "10.1007/s00259-020-04810-1",
language = "English",
volume = "47",
pages = "2887--2900",
journal = "EUR J NUCL MED MOL I",
issn = "1619-7070",
publisher = "Springer",
number = "12",

}

RIS

TY - JOUR

T1 - Reliable quantification of 18F-GE-180 PET neuroinflammation studies using an individually scaled population-based input function or late tissue-to-blood ratio

AU - Buchert, Ralph

AU - Dirks, Meike

AU - Schütze, Christian

AU - Wilke, Florian

AU - Mamach, Martin

AU - Wirries, Ann-Katrin

AU - Pflugrad, Henning

AU - Hamann, Linda

AU - Langer, Laura B N

AU - Wetzel, Christian

AU - Lukacevic, Mario

AU - Polyak, Andras

AU - Kessler, Mariella

AU - Petrusch, Carlotta

AU - Bengel, Frank M

AU - Geworski, Lilli

AU - Rupprecht, Rainer

AU - Weissenborn, Karin

AU - Ross, Tobias L

AU - Berding, Georg

PY - 2020/11

Y1 - 2020/11

N2 - PURPOSE: Tracer kinetic modeling of tissue time activity curves and the individual input function based on arterial blood sampling and metabolite correction is the gold standard for quantitative characterization of microglia activation by PET with the translocator protein (TSPO) ligand 18F-GE-180. This study tested simplified methods for quantification of 18F-GE-180 PET.METHODS: Dynamic 18F-GE-180 PET with arterial blood sampling and metabolite correction was performed in five healthy volunteers and 20 liver-transplanted patients. Population-based input function templates were generated by averaging individual input functions normalized to the total area under the input function using a leave-one-out approach. Individual population-based input functions were obtained by scaling the input function template with the individual parent activity concentration of 18F-GE-180 in arterial plasma in a blood sample drawn at 27.5 min or by the individual administered tracer activity, respectively. The total 18F-GE-180 distribution volume (VT) was estimated in 12 regions-of-interest (ROIs) by the invasive Logan plot using the measured or the population-based input functions. Late ROI-to-whole-blood and ROI-to-cerebellum ratio were also computed.RESULTS: Correlation with the reference VT (with individually measured input function) was very high for VT with the population-based input function scaled with the blood sample and for the ROI-to-whole-blood ratio (Pearson correlation coefficient = 0.989 ± 0.006 and 0.970 ± 0.005). The correlation was only moderate for VT with the population-based input function scaled with tracer activity dose and for the ROI-to-cerebellum ratio (0.653 ± 0.074 and 0.384 ± 0.177). Reference VT, population-based VT with scaling by the blood sample, and ROI-to-whole-blood ratio were sensitive to the TSPO gene polymorphism. Population-based VT with scaling to the administered tracer activity and the ROI-to-cerebellum ratio failed to detect a polymorphism effect.CONCLUSION: These results support the use of a population-based input function scaled with a single blood sample or the ROI-to-whole-blood ratio at a late time point for simplified quantitative analysis of 18F-GE-180 PET.

AB - PURPOSE: Tracer kinetic modeling of tissue time activity curves and the individual input function based on arterial blood sampling and metabolite correction is the gold standard for quantitative characterization of microglia activation by PET with the translocator protein (TSPO) ligand 18F-GE-180. This study tested simplified methods for quantification of 18F-GE-180 PET.METHODS: Dynamic 18F-GE-180 PET with arterial blood sampling and metabolite correction was performed in five healthy volunteers and 20 liver-transplanted patients. Population-based input function templates were generated by averaging individual input functions normalized to the total area under the input function using a leave-one-out approach. Individual population-based input functions were obtained by scaling the input function template with the individual parent activity concentration of 18F-GE-180 in arterial plasma in a blood sample drawn at 27.5 min or by the individual administered tracer activity, respectively. The total 18F-GE-180 distribution volume (VT) was estimated in 12 regions-of-interest (ROIs) by the invasive Logan plot using the measured or the population-based input functions. Late ROI-to-whole-blood and ROI-to-cerebellum ratio were also computed.RESULTS: Correlation with the reference VT (with individually measured input function) was very high for VT with the population-based input function scaled with the blood sample and for the ROI-to-whole-blood ratio (Pearson correlation coefficient = 0.989 ± 0.006 and 0.970 ± 0.005). The correlation was only moderate for VT with the population-based input function scaled with tracer activity dose and for the ROI-to-cerebellum ratio (0.653 ± 0.074 and 0.384 ± 0.177). Reference VT, population-based VT with scaling by the blood sample, and ROI-to-whole-blood ratio were sensitive to the TSPO gene polymorphism. Population-based VT with scaling to the administered tracer activity and the ROI-to-cerebellum ratio failed to detect a polymorphism effect.CONCLUSION: These results support the use of a population-based input function scaled with a single blood sample or the ROI-to-whole-blood ratio at a late time point for simplified quantitative analysis of 18F-GE-180 PET.

U2 - 10.1007/s00259-020-04810-1

DO - 10.1007/s00259-020-04810-1

M3 - SCORING: Journal article

C2 - 32322915

VL - 47

SP - 2887

EP - 2900

JO - EUR J NUCL MED MOL I

JF - EUR J NUCL MED MOL I

SN - 1619-7070

IS - 12

ER -